GUIDANT PIPELINE INCLUDES CORONARY STENTS, DIGITAL PTCA CATHETERS, IPO SAYS; LILLY DEVICE GROUP EXPECTS TO GROSS $246 MIL. IN INITIAL PUBLIC OFFERING
This article was originally published in The Gray Sheet
Product development projects underway at Eli Lilly device company Guidant include a balloon-expandable stent for coronary uses and a line of coronary angioplasty catheters that incorporates digital inflation control, the company says in a prospectus for an initial public offering filed Sept. 13 with the Securities and Exchange Commission.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.